I've been treating my MDA PCa-2b cells with a component that is known for creating apoptosis, but more interestingly this component is decreasing the expression of intracellular protein beta-arrestin 2, at this time we are trying to figure out the pathway behind it. I am currently looking at ERK; I've been treating my cells (that are already treated with the component) with Interluekin 8 (at difference concentrations) to see the affect of ERK, however I am not seeing much of a difference in the expression for ERK for both my treated cells and control cells. I'm trying to determine why I am not seeing a difference in ERK expression (especially in control cells) when treated with IL-8, possibly MDA-Pca 2b does not express in the CXCR1 and CXCR2 that is associated with IL-8. Any thoughts?